Filing Details
- Accession Number:
- 0001586852-19-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-29 16:17:35
- Reporting Period:
- 2019-01-25
- Accepted Time:
- 2019-03-29 16:17:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1586852 | Omid Farokhzad | C/O Selecta Biosciences, Inc. 480 Arsenal Way Watertown MA 02472 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-01-25 | 83,333 | $1.50 | 83,333 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- These securities are held by SAF-BND Trust, for which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.